The full text of the agreement between the United States, Mexico and Canada is available here. The USMCA is updating and replacing the 25-year-old North American Free Trade Agreement (NAFTA). Work on the new agreement took several years, had to be approved by both houses of Congress and required all three countries to certify that they were complying with the various measures of the agreement. Certifications were finalized earlier this year, allowing the agreement to enter into force. UsmCA rules will apply from July 1, 2020. Here`s a look at the sections of the USMCA that affect the FDA: the U.S., Mexico and Canada have reached an agreement to modernize NAFTA, which is 25 years old, into a high-level agreement of the 21st century. The new agreement between the United States and Mexico-Canada (USMCA) will support mutually beneficial trade, which will lead to freer markets, fairer trade and robust economic growth in North America. All industries that trade between Mexico and the EU will benefit directly or indirectly from the modernisation of this agreement. However, some sectors could benefit more, notably: the AGREEMENT between the EU and Mexico will not change the rules that require suppliers to comply, whether domestically or domestically: separately, on 11 May 2018, House of Representatives spokesman Paul Ryan set 17 May as the deadline for congressional action. This deadline was not met and the agreement with Mexico was not reached until August 27, 2018.  At that time, Canada had not approved the agreement.
Mexico`s outgoing President Enrique Pea Nieto, having left office on 1 December 2018 and requiring 60 days as a review period, the deadline for making the agreed text available was set at the end of September 2018, 30 September 2018. Negotiators worked around the clock and reached an agreement less than an hour before midnight on a draft text. The next day, October 1, 2018, the USMCA text was published as an agreed document. On June 19, 2019, the Mexican Senate ratified the agreement (114 yes, 3 no, 3 abstentions).  Mexico`s ratification process will be completed when the President announces its ratification to the Federal Register. The European Union and Mexico have reached an “agreement in principle” on the main trade parties of a new eu-Mexico association agreement. The new agreement replaces a previous agreement between the EU and Mexico in 2000. Negotiations began in 2016. In April, the EU and Mexico secured the intention of two parties to conclude a final text of the agreement by the end of 2018.
In addition to its work with the WTO, the United States has concluded trade agreements with 20 countries that cover a number of issues, ranging from tariffs on goods and access to the agricultural market to intellectual property and the environment. For the FDA, the specific themes are chapters of agreements on regulatory issues such as SPS measures, OBTs and good regulatory practices – as well as sector chapters on cosmetics, medical devices and drugs, if any.